Search clinical trials for: Hydrochlorothiazide and furosemide

Total 270823 results

Organon and Co

Completed

Antihypertensive Efficacy and Safety of Approved Drugs in Japanese Patients With Essential Hypertension (Banyu Study)(0954A-302)

Hypertension
Ankara University

Completed

Value of Renal Vascular Doppler Sonography in Management of Decompensated Heart Failure

Cardiorenal Syndrome

Turkey
Daiichi Sankyo, Inc.
Daiichi Sankyo Europe, GmbH, a Daiichi Sankyo Company

Completed

Combination of Olmesartan and Hydrochlorothiazide in Essential Hypertension

Essential Hypertension

Belgium, Germany, Netherlands, Slovakia
Boehringer Ingelheim

Completed

Randomized, Double-Blind, Placebo-Controlled, Forced-Titration, Comparing Telmisartan vs Valsartan. Taken Orally for Eight Weeks in Patients With Stage 1 and Stage 2 Hypertension

Hypertension

United States
Boehringer Ingelheim

Completed

A Randomized, Double-blind, Parallel-group Assessment of the Safety and Efficacy of Telmisartan 40mg Plus Hydrochlorothiazide 12.5mg (Micardis Plus) in Comparison With Losartan 50mg Plus Hydrochlorothiazide 12.5mg in Taiwanese Patients With Mild to Moderate Hypertension

Hypertension

Taiwan
Teva Pharmaceuticals USA

Completed

Losartan Potassium/Hydrochlorothiazide 100/25 mg Tablets in Healthy Subjects Under Fasting Conditions

Healthy

United States
University of Alberta
Alberta Heritage Foundation for Medical Research

Completed

Prevention of Contrast-Induced Nephropathy

Acute Renal Failure | Chronic Renal Failure | Contrast-induced Nephropathy

Canada
Novartis Pharmaceuticals

Terminated

A Randomized Controlled Trial of Aliskiren in the Prevention of Major Cardiovascular Events in Elderly People (APOLLO)

Cardiovascular Events

Colombia, India, South Africa, Canada, Spain, Hungary, United States, Germany, Ireland, Argentina, Philippines, Brazil, Sweden, Malaysia, Chile, Israel, Czech Republic, Netherlands
Unity Health Toronto
Canadian Institutes of Health Research (CIHR)

Not yet recruiting

Role of Active Deresuscitation After Resuscitation: (RADAR-Canada)

Sepsis | Critical Illness | Trauma | ARDS | Fluid Overload

Canada
Shiraz University of Medical Sciences

Recruiting

Effect of Furosemide on ESWL Outcomes for Renal and Ureteral Calculi

Nephrolithiasis | Urinary Calculi | Urolithiasis | Ureterolithiasis

Iran, Islamic Republic of
Boehringer Ingelheim

Completed

Post-marketing Surveillance Study With MicardisPlus® in Treatment of Morning Hypertension (Self-monitored by Patient)

Hypertension
Boehringer Ingelheim

Completed

SMOOTH - Blood Pressure Control in Diabetic/Obese Patients

Hypertension | Diabetes Mellitus, Type 2

Taiwan, Korea, Republic of, United States, New Zealand, Australia, Argentina, Canada, Mexico
Bayer

Completed

Effects of Telmisartan/Hydrochlorothiazide Treatment in Hypertensive Patients Under Real-life Setting (POTASSIUM)

Primary Hypertension

Poland
Organon and Co

Completed

Bioequivalence of Losartan and Hydrochlorothiazide (HCTZ) Combination Tablet and Coadministration of Its Components (0954A-306)

Hypertension
University of North Carolina, Chapel Hill
University of Illinois at Chicago; Virginia Commonwealth University

Terminated

Oral Metolazone and Intermittent Intravenous Furosemide Versus Continuous Infusion Furosemide in Acute Heart Failure

Acute Decompensated Heart Failure

United States
Stendhal Americas, S.A.

Completed

Efficacy and Safety of Fimasartan Alone or Combined With HCTZ in Mexican Patients With Essential Hypertension (FIRME-1)

Hypertension, Essential

Mexico
Ochsner Health System

Withdrawn

Combination Diuretic Therapy for Acute Decompensated Heart Failure (COMBIND-HF)

Acute Decompensated Heart Failure

United States
Ferrer Internacional S.A.

Completed

Effect of a New Formulation of Torasemide (Prolonged Release)on Myocardial Fibrosis in Patients With Heart Failure. (TORAFIC)

Congestive Heart Failure

Spain
Novartis

Completed

Efficacy and Safety of the Combination Aliskiren (300 mg) and Hydrochlorothiazide (25mg) to Aliskiren (300mg) Monotherapy in Patients With Staged II Hypertension (ACQUIRE)

Hypertension

Switzerland, Italy, Argentina, Germany, Turkey, United States, Ecuador, Guatemala
Boehringer Ingelheim

Completed

A Study of a Hypertensive Population Under Treatment With Micardis® and Micardis Plus® to Control the Early Morning BP Rise (SURGE II)

Hypertension
Takeda

Completed

Long-Term Safety of Azilsartan Medoxomil and Chlorthalidone Compared to Olmesartan Medoxomil and Hydrochlorothiazide in Participants With Hypertension and Kidney Disease

Safety

Ukraine, Germany, Poland, Bulgaria, Netherlands, Lithuania, Slovakia, Latvia
Boehringer Ingelheim

Completed

A Randomized, Double-blind, Placebo Controlled Comparison of Telmisartan Hydrochlorothiazide (HCT) and Valsartan HCT in Hypertension (HTN) Stage I/II Patients

Hypertension

United States
Daiichi Sankyo Europe, GmbH, a Daiichi Sankyo Company

Completed

Olmesartan Medoxomil Versus Losartan in Elderly and Very Elderly

Essential Hypertension

Germany
University Hospital Hradec Kralove
Masaryk University

Recruiting

The Impact of Inhaled Furosemide and Perorally Administered Levodropropizine on Dyspnea in Patients With Respiratory Diseases (INFURO)

Dyspnea

Czechia
National Cardiovascular Center Harapan Kita Hospital...

Completed

Low Dose Continuous Furosemide Effect on Cardiac Surgery Patients With Kidney Dysfunction

Chronic Kidney Disease | Cardiac Disease

Indonesia
Sodertalje Hospital

Completed

Kinetic Method to Detect Dehydration

Dehydration

Sweden
Tottori University Hospital

Completed

Effects of Spironolactone on Matrix Metalloproteinases (MMPs) in Heart Failure

Chronic Stable Heart Failure
Sarfez Pharmaceuticals, Inc.

Completed

Comparison of Once Daily 40 mg Torsemide With Twice-daily 40 mg Furosemide

Body Weight Changes

India
Nordsjaellands Hospital
Rigshospitalet, Denmark; Aalborg University Hospital

Terminated

Forced Fluid Removal in High Risk Acute Kidney Injury (FFAKI)

Critical Illness | Acute Kidney Injury | Fluid Overload

Denmark
Novartis

Completed

Efficacy and Safety of Valsartan Plus Hydrochlorothiazide in Fixed Dose Combination in Hypertensive Patients Not Controlled by the Free Combination of an Angiotensin Receptor Blocker Plus Hydrochlorothiazide

Hypertension

Switzerland, Germany
Profil Institut für Stoffwechselforschung GmbH

Completed

Empagliflozin and Sympathetic Nerve Traffic

Type 2 Diabetes Mellitus

Germany
The University of Texas Medical Branch, Galveston

Recruiting

Postpartum Management of Hypertension in Pregnancy With Hydrochlorothiazide

Pre-Eclampsia | Hypertension, Pregnancy-Induced | Postpartum Preeclampsia | Gestational Hypertension | Superimposed Pre-Eclampsia | Postpartum Pregnancy-Induced Hypertension

United States
Merck Sharp & Dohme LLC

Completed

A Study of MK-7145 Compared to Placebo and Hydrochlorothiazide for Lowering Blood Pressure in Male Participants With Hypertension (MK-7145-009)

Hypertension
Wroclaw Medical University

Recruiting

Sodium Chloride vs. Glucose Solute as a Volume Replacement Therapy During Decongestion in Acute Heart Failure (SOLVRED-AHF)

Heart Failure | Acute Heart Failure | Congestion

Poland
Assistance Publique - Hôpitaux de Paris

Unknown

Efficacy of Furosemide Versus Vascular Filling in Patients With Acute Myocardial Infarction (FAMIE)

Acute Myocardial Infarction With Right Ventricular Extension

France
Tottori University Hospital

Completed

Spironolactone and Insulin Resistance in Chronic Heart Failure (CHF)

Chronic Stable Heart Failure
Centre Oscar Lambret
National Cancer Institute, France

Terminated

Evaluation of the Efficacy of Diuretics for Symptomatic Malignant Ascites Episodes in Advanced Stage of Cancer (DIASC)

Cancer

France
Creighton University

Withdrawn

Chlorthalidone Compared to Hydrochlorothiazide on Endothelial Function

Hypertension

United States
University of Abuja
Imperial College London; University College Hospital, Ibadan; University of Nairobi and other collaborators

Completed

Comparison of Three Combination Therapies in Lowering Blood Pressure in Black Africans (Creole)

Hypertension

Nigeria
Roxane Laboratories

Completed

Crossover Bioequivalence Study of Irbesartan HCTZ 300/25 mg Tablets Under Fasted Conditions

Hypertension

United States
Boehringer Ingelheim

Completed

Pharmaco-epidemiological Study Describing a Population of Hypertensive Patients Treated With a Fixed-dose Combination of Telmisartan and Hydrochlorothiazide

Hypertension
Pfizer

Completed

Ramipril and Hydrochlorothiazide Alone and in Combination for the Treatment of Essential Hypertension

Hypertension | Blood Pressure, High

United States
Novartis

Completed

Hypertension and Cardiovascular Risk Factors

HYPERTENSION
Sanofi

Completed

Irbesartan/Hydrochlorothiazide National Taiwan University Hospital Listing

Hypertension

Taiwan
Sanofi

Completed

Irbesartan/Hydrochlorothiazide and Irbesartan in the Treatment of Mild to Moderate Hypertension

Hypertension

Taiwan
Shanghai Jiao Tong University School of Medicine

Recruiting

Efficacy and Safety of a Single-pill Fixed Combination of Sufficient Losartan/Hydrochlorothiazide in Chinese Hypertensive Patients

Hypertension

China
Pfizer

Completed

A Study to Learn How the Body Processes Spironolactone and Hydrochlorothiazide Film Coated Tablets Manufactured at Two Sites: Viatris and Neolpharma

Healthy Participants

United States
Insel Gruppe AG, University Hospital Bern
University of Bern

Not yet recruiting

Indapamide and Chlorthalidone to Reduce Urine Supersaturation for Kidney Stone Prevention (INDAPACHLOR)

Kidney Stone

Switzerland
Yonsei University

Completed

Randomized, Open Labeled Clinical Trial to Compare the Effectiveness of Amlodipine/Valsartan vs Hydrochlorothiazide/Telmisartan on Glucose Tolerance in Patients With Hypertension With Metabolic Syndrome

Hypertension

Korea, Republic of
Larissa University Hospital

Unknown

Dopamine in Acute Decompensated Heart Failure (DAD-HF) Trial (DAD-HF)

Acute Heart Failure

Greece

3

Subscribe